Anti-Ly6g antibody [EPR22909-135] (Ab238132)
Lymphocyte antigen 6G, Ly-6G, Ly-6G.1, Ly6g
详细信息
背景信息
Product Specifications Anti-Ly6g antibody [EPR22909-135] (ab238132) was developed by Abcam using patented rabbit monoclonal antibody technology and is validated for use in Flow Cyt, IHC-P in mouse samples. Anti-Ly6g antibody [EPR22909-135] (ab238132) specifically detects Ly6g (UniProt ID: P35461; Molecular weight: 14kDa) and is sold in a convenient trial size to enable initial testing (20 µL) and larger sizes for subsequent scaling up experiments (100 µL and 1 mL). Quality and Validation Abcam's high quality manufacturing and validation processes ensure Anti-Ly6g antibody [EPR22909-135] (ab238132) has high sensitivity and specificity alongside high lot-to-lot consistency and reproducibility. Anti-Ly6g antibody [EPR22909-135] (ab238132) has been cited over 45 times in peer reviewed journals and is trusted by the scientific community. Related Products Conjugation-ready, carrier free format available for antibody clone EPR22909-135 - ab261916. Antibody clone EPR22909-135 is also available pre-conjugated to a variety of labels for your convenience - Alexa Fluor® 488, Alexa Fluor® 647, PE, APC, Alexa Fluor® 594, FITC ( ab283276, ab303467, ab303605, ab303606, ab307167, ab322293 ). Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents. What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies.
文献引用 (144)
Nerves Stimulate Cross-talk Between Gastric Cancer and Group 3 Innate Lymphoid Cells to Enhance Immunosuppression.
神经刺激胃癌与第 3 组固有淋巴细胞之间的相互作用,从而增强免疫抑制。
Endothelium-Treg Communication Through Extracellular Vesicle Transfer Exacerbates Acute Respiratory Distress Syndrome
内皮细胞-Treg细胞通过细胞外囊泡转移进行通讯,加剧急性呼吸窘迫综合征
Clostridium perfringens alpha toxin drives pathological NETosis via immature neutrophil mobilization and functional reprogramming
产气荚膜梭菌α毒素通过动员未成熟中性粒细胞和功能重编程驱动病理性NETosis
A Time-Programmed Bilayer Wound Dressing for Dynamic Microenvironment Modulation and Full-Thickness Regeneration in Diabetic Wounds.
一种用于动态微环境调节和糖尿病伤口全层再生的定时双层伤口敷料。
Intestinal epithelial Smad7 drives purine metabolic dysregulation and ileal inflammation.
肠道上皮细胞 Smad7 驱动嘌呤代谢紊乱和回肠炎症。
A phase II study of docetaxel and pembrolizumab plus Interleukin-12 gene therapy in non-metastatic, anthracycline-refractory triple negative breast cancer (INTEGRAL).
一项针对非转移性、蒽环类药物难治性三阴性乳腺癌的多西他赛和帕博利珠单抗联合白细胞介素-12基因疗法的II期研究(INTEGRAL)。
IL-10R inhibition induces neutrophil tumoricidal activity.
IL-10R抑制可诱导中性粒细胞的杀瘤活性。
TNFα is a trigger of aging-associated liver inflammation in mice.
TNFα是小鼠衰老相关肝脏炎症的诱因。
APX3330 reverses the immunosuppressive tumor microenvironment during colorectal carcinogenesis.
APX3330 可逆转结直肠癌发生过程中的免疫抑制性肿瘤微环境。
- 1
- 2
- 3
- 4
- 5
- 6
- 15